Igci A - Search Results

1

A Hypofractionated Radiotherapy Schedule with a Simultaneous Integrated Boost for Breast Cancer: Outcomes including Late Toxicity and Health Quality.

Akgun Z, Cakir A, Sağlam E, Demirel S, Igci A, Keskin S. Akgun Z, et al. Among authors: igci a. Medicina (Kaunas). 2023 Mar 29;59(4):675. doi: 10.3390/medicina59040675. Medicina (Kaunas). 2023. PMID: 37109633 Free PMC article.

2

Clinical and pathological features of breast cancer associated with the pathological complete response to anthracycline-based neoadjuvant chemotherapy.

Keskin S, Muslumanoglu M, Saip P, Karanlık H, Guveli M, Pehlivan E, Aydoğan F, Eralp Y, Aydıner A, Yavuz E, Ozmen V, Igci A, Topuz E. Keskin S, et al. Among authors: igci a. Oncology. 2011;81(1):30-8. doi: 10.1159/000330766. Epub 2011 Sep 9. Oncology. 2011. PMID: 21912195

3

Predictive role of midtreatment changes in survivin, GSTP1, and topoisomerase 2α expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

Eralp Y, Keskin S, Akışık E, Akışık E, İğci A, Müslümanoğlu M, Yılmaz S, Tunacı M, Çamlıca H, Tuzlalı S, Saip P, Dalay N, Özmen V, Topuz E. Eralp Y, et al. Among authors: igci a. Am J Clin Oncol. 2013 Jun;36(3):215-23. doi: 10.1097/COC.0b013e318243913f. Am J Clin Oncol. 2013. PMID: 22441341

4

Two different formulations with equivalent effect? Comparison of serum estradiol suppression with monthly goserelin and trimonthly leuprolide in breast cancer patients.

Aydiner A, Kilic L, Yildiz I, Keskin S, Sen F, Kucucuk S, Karanlik H, Muslumanoglu M, Igci A. Aydiner A, et al. Among authors: igci a. Med Oncol. 2013 Mar;30(1):354. doi: 10.1007/s12032-012-0354-1. Epub 2012 Dec 29. Med Oncol. 2013. PMID: 23275115

5

Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy.

Gezer U, Keskin S, Iğci A, Tükenmez M, Tiryakioğlu D, Cetinkaya M, Dişci R, Dalay N, Eralp Y. Gezer U, et al. Among authors: igci a. Oncol Lett. 2014 Aug;8(2):845-848. doi: 10.3892/ol.2014.2188. Epub 2014 May 28. Oncol Lett. 2014. PMID: 25009660 Free PMC article.

6

Esophageal transection.

Özçınar B, Peker KD, Demirel S, Yanar F, Tuncer K, İğci A. Özçınar B, et al. Among authors: igci a. Ulus Cerrahi Derg. 2016 Dec 1;32(4):281-284. doi: 10.5152/UCD.2016.3232. eCollection 2016. Ulus Cerrahi Derg. 2016. PMID: 28149126 Free PMC article.

7

Inflammatory breast cancer: results of antracycline-based neoadjuvant chemotherapy.

Ozmen V, Cabioglu N, Igci A, Dagoglu T, Aydiner A, Kecer M, Bozfakioglu Y, Dinçer M, Bilir A, Topuz E. Ozmen V, et al. Among authors: igci a. Breast J. 2003 Mar-Apr;9(2):79-85. doi: 10.1046/j.1524-4741.2003.09204.x. Breast J. 2003. PMID: 12603379

8

Breast conserving surgery after primary chemotherapy in locally advanced breast cancer.

Asoglu O, Muslumanoglu M, Igci A, Ozmen V, Karanlik H, Ayalp K, Bozfakioglu Y, Kecer M, Parlak M. Asoglu O, et al. Among authors: igci a. Acta Chir Belg. 2005 Feb;105(1):62-8. Acta Chir Belg. 2005. PMID: 15790205

9

Increased lymph node positivity in multifocal and multicentric breast cancer.

Cabioglu N, Ozmen V, Kaya H, Tuzlali S, Igci A, Muslumanoglu M, Kecer M, Dagoglu T. Cabioglu N, et al. Among authors: igci a. J Am Coll Surg. 2009 Jan;208(1):67-74. doi: 10.1016/j.jamcollsurg.2008.09.001. Epub 2008 Oct 31. J Am Coll Surg. 2009. PMID: 19228505

10

Clinical importance of micrometastasis in sentinel lymph nodes.

Ozcinar B, Muslumanoglu M, Igci A, Gurdal SO, Yavuz E, Kecer M, Dagoglu T, Ozmen V. Ozcinar B, et al. Among authors: igci a. Breast. 2011 Feb;20(1):31-3. doi: 10.1016/j.breast.2010.08.005. Epub 2010 Sep 16. Breast. 2011. PMID: 20846864 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page